In the context of closed-loop glycemic control, MPC has shown the skillfulness to improve glucose regulation in patients with type 1 diabetes mellitus (T1DM). To reduce its complexity, many of the proposed control strategies have been designed based on linear time-invariant (LTI) models, without accounting for intraday parametric fluctuations. In this work, a pulsatile Zone Model Predictive Control (pZMPC) is examined under a realistic patterns of intraday insulin sensitivity ( SI ), according to the recent updates of the FDA-approved UVA/Padova simulator. Nominal updates of the postprandial insulin sensitivity are explicitly taken into account in the control-oriented model to improve the glucose predictions. The resulting controller is tested ‘in-silico’ with the FDA-approved UVA/Padova simulator, while its behavior is analyzed by comparing the usual statistical metrics with the corresponding time-invariant configuration. As expected, results show significant improvements, which justifies the (reasonable) increment in the controller complexity.
(2022). MPC-based artificial pancreas accounting for circadian variability of insulin sensitivity . Retrieved from https://hdl.handle.net/10446/234983
MPC-based artificial pancreas accounting for circadian variability of insulin sensitivity
Ferramosca, Antonio;
2022-01-01
Abstract
In the context of closed-loop glycemic control, MPC has shown the skillfulness to improve glucose regulation in patients with type 1 diabetes mellitus (T1DM). To reduce its complexity, many of the proposed control strategies have been designed based on linear time-invariant (LTI) models, without accounting for intraday parametric fluctuations. In this work, a pulsatile Zone Model Predictive Control (pZMPC) is examined under a realistic patterns of intraday insulin sensitivity ( SI ), according to the recent updates of the FDA-approved UVA/Padova simulator. Nominal updates of the postprandial insulin sensitivity are explicitly taken into account in the control-oriented model to improve the glucose predictions. The resulting controller is tested ‘in-silico’ with the FDA-approved UVA/Padova simulator, while its behavior is analyzed by comparing the usual statistical metrics with the corresponding time-invariant configuration. As expected, results show significant improvements, which justifies the (reasonable) increment in the controller complexity.File | Dimensione del file | Formato | |
---|---|---|---|
MPC-based_artificial_pancreas_accounting_for_circadian_variability_of_insulin_sensitivity.pdf
Solo gestori di archivio
Versione:
publisher's version - versione editoriale
Licenza:
Licenza default Aisberg
Dimensione del file
1.67 MB
Formato
Adobe PDF
|
1.67 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
Aisberg ©2008 Servizi bibliotecari, Università degli studi di Bergamo | Terms of use/Condizioni di utilizzo